Skip navigation
Universidade Federal da Bahia |
Repositório Institucional da UFBA
Use este identificador para citar ou linkar para este item: https://repositorio.ufba.br/handle/ri/13912
Registro completo de metadados
Campo DCValorIdioma
dc.contributor.authorMello, Vivianne Barretto de-
dc.contributor.authorCruz, Thomaz Rodrigues Porto da-
dc.contributor.authorNuñez, Geila Ribeiro-
dc.contributor.authorSimões, Maria Tereza-
dc.contributor.authorBraga, Hélio Jose Vieira-
dc.contributor.authorAraújo, César-
dc.contributor.authorCunha, Simone Muniz Carvalho Fernandes da-
dc.contributor.authorSchinoni, Maria Isabel-
dc.contributor.authorCruz, Marla-
dc.contributor.authorParaná, Raymundo-
dc.creatorMello, Vivianne Barretto de-
dc.creatorCruz, Thomaz Rodrigues Porto da-
dc.creatorNuñez, Geila Ribeiro-
dc.creatorSimões, Maria Tereza-
dc.creatorBraga, Hélio Jose Vieira-
dc.creatorAraújo, César-
dc.creatorCunha, Simone Muniz Carvalho Fernandes da-
dc.creatorSchinoni, Maria Isabel-
dc.creatorCruz, Marla-
dc.creatorParaná, Raymundo-
dc.date.accessioned2013-11-26T13:07:53Z-
dc.date.issued2006-
dc.identifier.issn0146-6615-
dc.identifier.urihttp://repositorio.ufba.br/ri/handle/ri/13912-
dc.descriptionTexto completo: acesso restrito. p. 1406–1410pt_BR
dc.description.abstractPatients with hepatitis C virus (HCV) infection present higher risk of developing type-2 diabetes mellitus (DM). However, the mechanism of this association and the role of antiviral treatment are still unclear. The objective of this study was to investigate the relationship between the use of peguilated interferon and the development of insulin resistance (IR) in these patients. Methods: HOMA index was evaluated in 30 HCV-infected patients just before and during the first 6 months of treatment with peguilated interferon plus ribavirin. Anthropometrical parameters and glucose/cholesterol profile were also monitored. Results: No changes in HOMA after 6 months of treatment were observed. Glucose levels decreased but not significantly (P = 0.059). Patients with higher HOMA index after 6 months of treatment also presented higher aminotransferase levels (P = 0.03), higher fat index on computed tomography (P = 0.011), longer time of exposure to the virus (P = 0.021), and a positive smoking history when compared to non-insulin resistant patients (P = 0.045). There was no influence of fibrosis stage on liver biopsy in the insulin-resistance development. Conclusions: No changes in the IR were observed after 6 months of treatment. Insulin resistance is related to the abdominal fat and anthropometrical parameters rather than to the antiviral treatment. J. Med.pt_BR
dc.language.isoenpt_BR
dc.rightsAcesso Abertopt_BR
dc.sourcehttp://dx.doi.org/10.1002/jmv.20712pt_BR
dc.subjectInterferonpt_BR
dc.subjectPeripheral insulin resistancept_BR
dc.subjectVirus c hepatitispt_BR
dc.subjectDiabetes mellituspt_BR
dc.titlePeripheral insulin resistance during treatment of chronic hepatitis C with peguilated interferon plus ribavirinpt_BR
dc.title.alternativeJournal of Medical Virologypt_BR
dc.typeArtigo de Periódicopt_BR
dc.identifier.numberv. 78, n. 11pt_BR
dc.embargo.liftdate10000-01-01-
Aparece nas coleções:Artigo Publicado em Periódico (Faculdade de Medicina)

Arquivos associados a este item:
Arquivo Descrição TamanhoFormato 
20712_ftp.pdf96,76 kBAdobe PDFVisualizar/Abrir
Mostrar registro simples do item Visualizar estatísticas


Os itens no repositório estão protegidos por copyright, com todos os direitos reservados, salvo quando é indicado o contrário.